Cargando…
艾曲泊帕、重组人血小板生成素联合标准免疫抑制治疗重型再生障碍性贫血16例疗效及安全性分析
OBJECTIVE: To evaluate the efficacy and safety of combination therapy of eltrombopag, recombinant human thrombopoietin (rhTPO), and standard immunosuppressive therapy (IST) for severe aplastic anemia (SAA). METHODS: A total of 16 cases with SAA treated with IST combined with eltrombopag and rhTPO we...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770875/ https://www.ncbi.nlm.nih.gov/pubmed/35045674 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.12.010 |